Distress Respiratory Syndrome: Clinical Trials

6 trials for Distress Respiratory Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting, 1 enrolling by invitation, 1 unknown. 2 Phase 2, 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Not applicable1Unknown 1
Phase 41Active not recruiting 1

Follow Distress Respiratory Syndrome: new trials by email Literature Review of Distress Respiratory Syndrome trials Research Report on Distress Respiratory Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Hydrocortisone Versus Regular Treatment in Shock in Extremely Preterm Neonates - an Open Randomized Controlled Trial
Intravascular Hydrocortisone (stress dosage): 1 mg/k/dose each 8 hours for 5 days, Vasoactive drug therapies - Shock, Preterm Birth Complication
Phase 4Active not recruitingCoordinación de Investigación en Salud, Mexico762025-02-012025-11-25
Adverse Neonatal Outcomes With a Shortened Clinical Regimen of Dexamethasone.
Dexamethasone 12 mg QD, Dexamethasone 6 mg BID - Preterm Birth, Distress Respiratory Syndrome
Phase 2CompletedRicardo A Gutierrez Ramirez, MD, MSc, FACOG682024-03-012024-11-27
Differential Diagnosis of Persistent COVID-19 by Artificial Intelligence
Experimental tests - COVID-19, Fatigue
Not applicableUnknownFundacin Biomedica Galicia Sur1362022-12-142022-11-29
The Medical Management in Patients Exposed to Weapons of Mass Destruction
Clinical interventions performed in acute settings (contaminated environment), Protection (clinician and patient), Decontamination (clinician and patient) - Chemical Injury, Chemicals; Intoxication
Enrolling by invitationSt. Justine's Hospital10002020-10-012025-10-01
Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19
Antithrombin + best available treatment, Best available treatment - Covid19, Severe Acute Respiratory Syndrome
Phase 2CompletedMaimónides Biomedical Research Institute of Córdoba482020-04-272021-02-09
Pressure Support Ventilation Versus Neurally Adjusted Ventilatory Assist in Difficult to Wean Pediatric Patients
pressure support ventilation versus neurally adjusted ventilatory assist - Distress Respiratory Syndrome, Weaning Failure
CompletedFondazione Policlinico Universitario Agostino Gemelli IRCCS122011-01-012021-10-06

Narrower conditions

Pulmonary Atelectasis (6)  ·  COVID-19 (2)  ·  Cognitive Dysfunction (1)  ·  Enterocolitis, Necrotizing (1)  ·  Fatigue (1)  ·  Hyperglycemia (1)  ·  Intestinal Perforation (1)  ·  Neonatal Sepsis (1)  ·  Premature Birth (1)  ·  Respiratory Distress Syndrome (1)  ·  Severe Acute Respiratory Syndrome (1)  ·  Shock (1)

Broader conditions

Lung Diseases (6)  ·  Respiratory Tract Diseases (6)  ·  Infections (3)  ·  Coronaviridae Infections (2)  ·  Coronavirus Infections (2)  ·  Nidovirales Infections (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)  ·  Cognition Disorders (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)

Interventions

Antithrombins (1)  ·  BID protein, human (1)  ·  Decontamination (1)  ·  Dexamethasone (1)

Sponsors

Coordinación de Investigación en Salud, Mexico (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Fundacin Biomedica Galicia Sur (1)  ·  Maimónides Biomedical Research Institute of Córdoba (1)  ·  Ricardo A Gutierrez Ramirez, MD, MSc, FACOG (1)  ·  St. Justine's Hospital (1)

Countries

Spain (2)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Honduras (1)  ·  Japan (1)  ·  Mexico (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Giorgio P Conti, Prof (1)  ·  Ricardo A Gutierrez Ramirez, MD, MSc (1)  ·  Stephane Bourassa (1)

Results publications

PMID 23990333, PMID 29779863, PMID 32631305, PMID 36175098